These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 15058523

  • 1. Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease.
    Thomas CW, Weinshenker BG, Sandborn WJ.
    Inflamm Bowel Dis; 2004 Jan; 10(1):28-31. PubMed ID: 15058523
    [Abstract] [Full Text] [Related]

  • 2. Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.
    Dubcenco E, Ottaway CA, Chen DL, Baker JP.
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):565-6. PubMed ID: 16607158
    [Abstract] [Full Text] [Related]

  • 3. Association of anti-tumor necrosis factor therapy with the development of multiple sclerosis.
    Enayati PJ, Papadakis KA.
    J Clin Gastroenterol; 2005 Apr; 39(4):303-6. PubMed ID: 15758624
    [Abstract] [Full Text] [Related]

  • 4. Demyelination-like syndrome in Crohn's disease after infliximab therapy.
    Freeman HJ, Flak B.
    Can J Gastroenterol; 2005 May; 19(5):313-6. PubMed ID: 15915246
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibody therapy for Crohn's disease.
    Selby W.
    Intern Med J; 2001 Mar; 31(2):73-4. PubMed ID: 11480481
    [No Abstract] [Full Text] [Related]

  • 6. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease.
    Vadikolias K, Kouklakis G, Heliopoulos I, Argyropoulou P, Papanas N, Tzilonidou M, Prassopoulos P, Piperidou H.
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):159-62. PubMed ID: 17273002
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience.
    Cohen RD.
    Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S17-22. PubMed ID: 11380038
    [Abstract] [Full Text] [Related]

  • 8. New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients.
    Tanno M, Nakamura I, Kobayashi S, Kurihara K, Ito K.
    Clin Rheumatol; 2006 Nov; 25(6):929-33. PubMed ID: 16328088
    [Abstract] [Full Text] [Related]

  • 9. Infliximab treatment for Crohn's disease.
    Conroy CA, Cattell R.
    Postgrad Med J; 2001 Jul; 77(909):436-40. PubMed ID: 11423591
    [No Abstract] [Full Text] [Related]

  • 10. Severe agranulocytosis following first infliximab infusion in Crohn's disease.
    Rosales-Zábal JM, Fernández-Pérez F, Albandea-Moreno C, Vera-Rivero FM, Navarro-Jarabo JM.
    Inflamm Bowel Dis; 2011 Nov; 17(11):E147-8. PubMed ID: 21830280
    [No Abstract] [Full Text] [Related]

  • 11. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease.
    Izbéki F, Nagy F, Szepes Z, Kiss I, Lonovics J, Molnár T.
    Inflamm Bowel Dis; 2008 Mar; 14(3):429-31. PubMed ID: 17973302
    [No Abstract] [Full Text] [Related]

  • 12. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
    Carroccio A, Di Prima L, Pirrone G, Ambrosiano G, Noto D, Cefalù AB.
    Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pericarditis as a complication of infliximab therapy in Crohn's disease.
    Burke JP, Kelleher B, Ramadan S, Quinlan M, Sugrue D, O'Donovan MA.
    Inflamm Bowel Dis; 2008 Mar; 14(3):428-9. PubMed ID: 17924565
    [No Abstract] [Full Text] [Related]

  • 15. [Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].
    Holtmann M, Wanitschke R, Helisch A, Bartenstein P, Galle PR, Neurath M.
    Z Gastroenterol; 2003 Jan; 41(1):11-7. PubMed ID: 12541166
    [Abstract] [Full Text] [Related]

  • 16. Psoriasis induced by infliximab in a patient suffering from Crohn's disease.
    Manni E, Barachini P.
    Int J Immunopathol Pharmacol; 2009 Jan; 22(3):841-4. PubMed ID: 19822070
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Indications and results of infliximab in Crohn's disease].
    Karoui S, Boubaker J, Filali A.
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Infliximab infusion reactions: desensitizing ourselves to the danger.
    Persley KM.
    Inflamm Bowel Dis; 2004 Jan; 10(1):62-3. PubMed ID: 15058530
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.